Biopolymers play a pivotal role in the pharmaceutical field, offering innovative solutions and addressing key challenges in drug delivery, tissue engineering, and biomedical applications. These natural or synthetic polymers derived from living organisms exhibit remarkable biocompatibility and biodegradability, making them ideal candidates for various pharmaceutical formulations. Biopolymers such as chitosan, alginate, and hyaluronic acid have gained prominence due to their unique properties, including mucoadhesion, controlled release, and the ability to enhance drug stability.
In drug delivery systems, biopolymers contribute to sustained drug release, improving therapeutic efficacy while minimizing adverse effects. Moreover, biopolymer-based scaffolds are employed in tissue engineering to support cell growth and tissue regeneration. Their versatility extends to applications like wound healing and surgical implants. The use of biopolymers aligns with the growing emphasis on sustainable and eco-friendly practices in the pharmaceutical industry. As research in biopolymer science advances, the development of novel formulations and delivery systems continues to shape the future of drug development, offering safer and more effective solutions for patient care.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico